Chlordiazepoxide Hydrochloride/Clidinium Bromide - Chlordiazepoxide Hydrochloride and Clidinium Bromide
Navigation: NDC > Supplier starting with: A > AVKARE, INC.| Field | Value |
|---|---|
| NDC Code: | 42291-214 |
| Proprietary Name: | Chlordiazepoxide Hydrochloride/Clidinium Bromide |
| Suffix: | |
| Non-Proprietary Name: | Chlordiazepoxide Hydrochloride and Clidinium Bromide |
| Dosage Form: | CAPSULE |
| Method: | ORAL |
| Original Marketing Date: | 19-11-2013 |
| Category Name: | UNAPPROVED DRUG OTHER |
| Application Number: | |
| Labeler: | AVKARE, INC. |
| Substance Name: | CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE |
| Active Numerator Strength: | 5; 2.5 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient],Anticholinergic [EPC],Decreased Parasympathetic Acetylcholine Activity [PE],GI Motility Alteration [PE],Digestive/GI System Activity Alteration [PE],Cholinergic Antagonists [MoA] |
| DEA Schedule: |